Skip to Main Content

An official website of the United States government

Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.

Name Principal Investigator Institution Study Date Approved Project ID
The Use of Machine Learning to predict if patients with Renal Cancer will surivive or not Vineel Ramineni Academies of Loudoun PLCO Feb 27, 2023 PLCO-1169
The use of marginal structural model to determine the effect of non-steroidal anti-inflammatory drug use on the risk of prostate and ovarian cancer Omonefe Omofuma University of south Carolina PLCO Mar 17, 2017 PLCO-265
The utility of CT-based nodule characteristics and polygenic risk score in the setting of a lung cancer screening trial. Gerard Silvestri Medical University of South Carolina NLST Mar 11, 2024 NLST-1201
Thoracic Disease Classification and Localization on Chest X-rays Junzhou Huang The University of Texas at Arlington PLCO Aug 20, 2018 PLCO-391
Threshold quantile regression models with applications to PSA data Eun Ryung Lee Sungkyunkwan University PLCO Jan 7, 2022 PLCO-893
Thyroid Cancer and NSAIDs Jigarkumar Patel NCI, DCP, GOCRG PLCO Mar 12, 2014 PLCO-69
Thyroid Cancer and NSAIDs: A Pooled Analysis Naris Nilubol NCI, CCR, EOB PLCO Nov 2, 2012 PLCO-1
Thyroid carcinoma relation with ovaries using Machine Learning Techniques Geetanjali Rave Ramaiah Institute of Technology NLST Mar 2, 2022 NLST-890
Thyroid disease prediction using machine learning algorithm Sneha Maria George Christ(Deemed to be University) PLCO Apr 16, 2021 PLCO-773
Thyroid Hormones, Thyroid Status, and Risk of Prostate Cancer Alison Mondul NCI PLCO Apr 27, 2012 2012-0027
Time course of biomarkers Paul Pinsky DCP, NCI PLCO Jan 18, 2024 PLCO-1454
Time Lag to Benefit: A Systematic Review and Meta-Analysis of Lung Cancer Screening Trials Alison Rustagi University of California, San Francisco NLST Oct 18, 2022 NLST-972
Time Lag to Benefit: A Systematic Review and Meta-Analysis of Lung Cancer Screening Trials Alison Rustagi University of California, San Francisco LSS Oct 27, 2022 LSS-3
Time-specific measures of benefits due to screening Olli Saarela University of Toronto NLST Sep 10, 2015 NLST-158
Time to benefit for lung cancer screening from low-dose computed tomography Tao Chen Xi'an Jiaotong University NLST Jun 26, 2023 NLST-1089
Time to benefit for lung cancer screening from low-dose computed tomography Tao Chen Xi'an Jiaotong University LSS Jul 19, 2023 LSS-6
Time to Event Prediction Based on Risk Calculation from Biomarkers Anna Lokshin University of Pittsburgh PLCO Sep 4, 2018 PLCO-395
Time to Event Prediction Based on Risk Calculation from Biomarkers Anna Lokshin University of Pittsburgh PLCO Jan 28, 2021 PLCO-717
Time To First Cigarette and Lung cancer, as well as other smoking related diseases Fangyi Gu National Cancer Institute NLST Mar 14, 2014 NLST-65
Time-Varying Measurement Error Models Raymond Carroll Texas A&M University IDATA Mar 20, 2017 IDATA-10